Goldman Sachs Group Inc Bausch Health Companies Inc. Transaction History
Goldman Sachs Group Inc
- $613 Billion
- Q4 2024
A detailed history of Goldman Sachs Group Inc transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 481,052 shares of BHC stock, worth $3.06 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
481,052
Previous 3,443,498
86.03%
Holding current value
$3.06 Million
Previous $28.1 Million
86.19%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding BHC
# of Institutions
264Shares Held
256MCall Options Held
5.53MPut Options Held
16.6M-
Icahn Carl C Sunny Isles Beach, FL34.7MShares$221 Million2.88% of portfolio
-
Goldentree Asset Management LP New York, NY29.4MShares$187 Million21.8% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny26.4MShares$168 Million14.7% of portfolio
-
National Bank Of Canada15.4MShares$98.1 Million0.17% of portfolio
-
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A613MShares$82.7 Million0.26% of portfolio
About Bausch Health Companies Inc.
- Ticker BHC
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 361,728,000
- Market Cap $2.3B
- Description
- Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...